Filling the gap between Guidelines and Real World in the cardiovascular approach to the diabetic patients: the need for a call to action

Francesco Maranta; Lorenzo Cianfanelli; Manfredi Rizzo; Domenico Cianflone

doi:10.1016/j.ijcard.2020.12.074

Filling the gap between Guidelines and Real World in the cardiovascular approach to the diabetic patients: the need for a call to action

Int J Cardiol. 2021 Apr 15:329:205-207. doi: 10.1016/j.ijcard.2020.12.074. Epub 2020 Dec 31.

Authors

Francesco Maranta¹, Lorenzo Cianfanelli², Manfredi Rizzo³, Domenico Cianflone⁴

Affiliations

¹ Cardiac Rehabilitation Unit, San Raffaele Scientific Institute, Milan, Italy. Electronic address: maranta.francesco@hsr.it.
² Cardiac Rehabilitation Unit, San Raffaele Scientific Institute, Milan, Italy.
³ Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy; Department of Medicine, School of Medicine, University of South Carolina, Columbia, SC, USA.
⁴ Cardiac Rehabilitation Unit, San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.

PMID: 33388398
DOI: 10.1016/j.ijcard.2020.12.074

No abstract available

Keywords: Cardiovascular outcome trials; Cardiovascular prevention; Cardiovascular risk; Diabetes mellitus type 2; Glucose-lowering drugs; Therapeutical targets.

MeSH terms

Blood Glucose
Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / therapy
Diabetes Mellitus, Type 2*
Humans
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors*

Substances

Blood Glucose
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors